PageGroup (PAGE); full year results show PBT increased 20.4% to £142.3m for FY18
The company witnessed record gross profit for 23 countries
PageGroup announced its full year results for the period ending 31 December 2018. Revenue rose 13.0% to £1,549.9m. Gross and operating profit grew by 15.9% and 20.7%, respectively. Basic EPS stood at 32.5p (FY17: 26.5p). Conversion rate was up 17.5% (FY17: 16.6%) and total ordinary dividend increased 4.8% to 13.1p.
Read more...Debenhams (DEB); again lowers expectations
Debenhams has again lowered expectations following a continued negative trading record. Observers will be forgiven for disagreeing that gross transaction value of sales down 5.0% in Q2 compared with 5.6% in Q1 represents much of a moderation in headwinds.
Read more...4imprint Group (FOUR); underlying EPS up 22% year-on-year for FY18
The Board recommended a 23% increase in final dividend per share
Today, 4imprint reported underlying EPS of 22% year-on-year (YOY) for FY18. New customer orders increased 14% YoY, while orders from existing customers rose 19% YoY. 4imprint is a producer and direct marketer of promotional products, based mostly in the US and Canada, where it retained 97% of its 2017 revenues.
Read more...Telford Homes (TEF); select M&G and Invesco as partners for their build-to-rent projects
Both the partners have signed partnership agreements with the group for an initial three-year period
Telford Homes declared that the group has selected Invesco Real Estate & M&G Real Estate as long-term investment partners for future build-to-rent projects.
Read more...BioPharma Credit (BPCR); FY18 results: NAV per share remains flat YoY at $1.00
BioPharma Credit announced its annual results for the period ending 31 December 2018. Net assets stood at $1,380.0m. The company’s share price was $1.0650. The company secured three new investments totalling $494m.
Read more...XP Power (XPP); reports 6% increase in diluted EPS for FY18
Board recommends final dividend per share of 33p for 4Q18
XP today reported that during the year ended 31 December 2018, revenue increased 17% to £195.1m. Order intake increased 8% YoY to £198.4m. Gross margin expanded 80bps to 47.3%, largely driven by improved product mix, better performance of Comdel and the appreciation of Sterling against US dollar.
Read more...Euromoney Institutional Investor (ERM); proposed distribution of shares to participating shareholder
The existing relationship deed between both the companies will terminate
Daily Mail and General Trust (DGMT) announced the proposed distribution of all its shares in Euromoney, a company in which it holds a 49% stake.
Read more...Shield Therapeutics (STX); positive results for Feraccru® in AEGIS-H2H non-inferiority study
Shield announced positive results from a multinational Phase IIIb randomised active-controlled trial. The trial compared Feraccru® (ferric maltol), a novel oral iron replacement therapy, to Ferinject® (ferric carboxymaltose), the market-leading intravenously delivered iron replacement therapy.
Read more...Marshall Motor Holdings (MMH); completes two acquisitions of six ŠKODA franchised dealerships
The company is now the UK's largest ŠKODA retailer
Marshall Motor Holdings completed two acquisitions comprising six ŠKODA franchised dealerships to become the UK’s largest ŠKODA retailer. The company paid £3.5m as aggregate consideration for the acquired businesses.
Read more...Rotork (ROR); PBT increases 49.8% to £120.7m for FY18
Strong OCC revenue growth at +11.3%
Rotork’s posted results today, stating that revenue increased 8.3% to £695.7m. Adjusted operating profit and basic EPS grew 12.2% and 64.1%, respectively. Net cash stood at £43.6m at year-end.
Read more...